Cognex Cash Flow from Operating Activities 2010-2023 | CGNX

Cognex annual/quarterly cash flow from operating activities history and growth rate from 2010 to 2023. Cash flow from operating activities can be defined as a company's cash flows from operations.
  • Cognex cash flow from operating activities for the quarter ending December 31, 2023 was $0.113B, a 53.61% decline year-over-year.
  • Cognex cash flow from operating activities for the twelve months ending December 31, 2023 was $0.296B, a 47.44% decline year-over-year.
  • Cognex annual cash flow from operating activities for 2023 was $0.113B, a 53.61% decline from 2022.
  • Cognex annual cash flow from operating activities for 2022 was $0.243B, a 22.5% decline from 2021.
  • Cognex annual cash flow from operating activities for 2021 was $0.314B, a 29.56% increase from 2020.
Cognex Annual Cash Flow Ops
(Millions of US $)
2023 $113
2022 $243
2021 $314
2020 $242
2019 $253
2018 $223
2017 $224
2016 $182
2015 $128
2014 $164
2013 $95
2012 $101
2011 $86
2010 $76
2009 $12
Sector Industry Market Cap Revenue
Computer and Technology Electrical Test Equipment $7.951B $0.838B
Cognex Corporation designs, develops, manufactures, and markets machine vision systems, or computers that can `see.` Cognex is the world's leader in the machine vision industry, having shipped more than 200,000 vision systems, representing nearly $1.5 billion in cumulative revenue, since the company's founding time. Cognex's Modular Vision Systems Division, headquartered in Natick, Massachusetts, specializes in machine vision systems that are used for automating the manufacture of a wide range of discrete items and for assuring their quality. Cognex's Surface Inspection Systems Division, headquartered in Alameda, California, specializes in machine vision systems that are used for inspecting the surfaces of products manufactured in a continuous fashion, such as metals, papers and plastics.
Stock Name Country Market Cap PE Ratio
Agilent Technologies (A) United States $41.848B 26.59
AMETEK (AME) United States $39.151B 25.90
Fortive (FTV) United States $26.941B 21.80
Teradyne (TER) United States $18.801B 41.67
Itron (ITRI) United States $5.003B 26.60